Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-03-10
1996-04-30
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
540547, A61K 3155, C07D28114
Patent
active
055125611
ABSTRACT:
The present invention provides substituted dibenzoxazepine compounds of Formula I: ##STR1## which are useful as analgesic agents for the treatment of pain, and for the treatment of prostaglandin E.sub.2 -mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal, and a method for treating prostaglandin E.sub.2 -mediated diseases in an animal, comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.
REFERENCES:
patent: 2852528 (1958-09-01), H ffmann et al.
patent: 3210372 (1965-10-01), Werner et al.
patent: 3357998 (1967-12-01), Cusic et al.
patent: 3534019 (1970-10-01), Coyne et al.
patent: 3624104 (1971-11-01), Cusic et al.
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1976-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
patent: 4290953 (1981-09-01), Koizumi et al.
patent: 4360525 (1982-11-01), Muller
patent: 4379150 (1983-04-01), Ito et al.
patent: 4559336 (1985-12-01), Mueller
patent: 4559337 (1985-12-01), Mueller
patent: 4614617 (1986-09-01), Mueller
patent: 4681939 (1904-07-01), Mueller
patent: 4704386 (1987-11-01), Mueller
patent: 4888335 (1989-12-01), Mohrbacher et al.
patent: 5180720 (1993-01-01), Husa et al.
patent: 5182272 (1993-01-01), Hallinan et al.
patent: 5189033 (1993-02-01), Tucker
patent: 5212169 (1993-05-01), Husa et al.
patent: 5225417 (1993-07-01), Dappen et al.
patent: 5281590 (1994-01-01), Husa et al.
patent: 5283240 (1994-02-01), Hallinlan et al.
patent: 5288719 (1994-02-01), Husa et al.
patent: 5304644 (1994-04-01), Husa et al.
patent: 5311101 (1994-05-01), Oldfield et al.
patent: 5324722 (1994-06-01), Hagen et al.
patent: 5354746 (1994-10-01), Chandrakumar et al.
patent: 5354747 (1994-10-01), Hansen et al.
patent: 5354863 (1994-10-01), Dappen et al.
A. Bennett, et al. "Antagonism of Prostanoid-Induced Contractions of Rat Gastric Fundus Muscle by SC-19220 Sodium Meclofenamate, Indomethacin or Trimethoquinol," Br. J. Pharmac., 71, 169-175 (1980)--London.
W. E. Coyne et al. "Anticonvulsant Semicarbazides," J. Med. Chem., 11(6), 1158-1160 (1968)-USA.
E. J. Drower, et al. "The Antiociceptive Effects of Prostaglandin Antagonists in the Rat," European Journal of Pharmacology, 133, 249-256 (1987)--Europe.
F. R. George, et al. "Antagonism of Alcohol Hypnosis by Blockade of Prostaglandin Synthesis and Activity: Genotype and Time Course Effects," Pharmacology, Biochemistry & Behavior, vol. 19, 131-136 (1983)--USA.
R. Gimet, et al. "Quantitative Determination of Polymorphic Forms in a Formulation Matrix Using the Near Infra-Red Reflectance Analysis Technique," Journal of Pharmaceutical & Biomedical Analysis, vol. 5, No. 3, 205-211 (1987)--Great Britain.
A. Gomes, et al. "Pharmacodynamics of Venom of the Centipede Scolopendra Subspinipes Dehaani," Indian Journal of Experimental Biology, vol. 20, 615-618, Aug. (1982)--India.
K. Gyires, et al. "The Use of the Writhing Test in Mice for Screening Different Types of Analgesics," Arch. Int. Pharmacodyn, 267, 131-140 (1984)--USA.
D. E. MacIntyre, et al. "Antagonism of Human Platelet Responses to Stimulatory and Inhibitory Prostaglandins," Prog. Lipid. Res., 20 (1-4), 453-9 (1981)--USA.
C. A. Maggi, et al. "The Effect of SC-19220, a Prostaglandin Antagonist, on the Micturition Reflex in Rats," European Journal of Pharmacology, 152, 273-279 (1988)--Europe.
K. Nagarajan, et al. "Synthesis of 10,11-Dihydrodibenz b,f! 1,4!oxazepine Derivatives as Potential Anticonvulsant & Psychotropic Agents," Indian Journal of Chemistry, vol. 24B, 840-844 (1985)--India.
S. Nakajyo, et al. "Inhibitory Effect of the Bassianolide Encyclodepepsipeptide, on Drug-Induced Contractions of Isolated Smooth Muscle Preparations" Japan J. Pharmacol., 32, 55-64 (1982)--Japan.
Chandrakumar Nizal S.
Huang Horng-Chih
Mueller Richard A.
Bond Robert T.
G. D. Searle & Co.
Hastreiter Roberta L.
Williams Roger A.
LandOfFree
Aryl substituted dibenzoxazepine compounds, pharmaceutical compo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl substituted dibenzoxazepine compounds, pharmaceutical compo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl substituted dibenzoxazepine compounds, pharmaceutical compo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-628821